Lnc2Cancer

Experimentally Supported Human LncRNA and Cancer Associations Database

LncRNA centric

Cancer centric

Advanced search

Drug resistant

Circulating

Prognosis

Detail


   LncRNA Name MEG3
   Synonyms MEG3, FP504, GTL2, LINC00023, NCRNA00023, PRO0518, PRO2160, onco-lncRNA-83, prebp1
   Region GRCh38_14:100779410-100861031    Sequence
   Ensembl ENSG00000214548
   RefSeq NR_002766
   Circulating
   Drug-resisitant
   Prognostic
   MiRNA
   Variant
   TF
   Methylation
   Cancer Name non-functioning pituitary adenoma
   ICD-0-3 C75.1  M8272/0
   Methods qPCR etc.
   Sample pituitary tumor tissues
   Expression Pattern down-regulated
   Function Description

In the present study we investigated the mechanism underlying the absence of MEG3 expression in human clinically nonfunctioning pituitary tumors. No genomic abnormality was detected in the tumors examined. Instead, we found that two 5'-flanking regions, immediately in front of and approximately 1.6-2.1 kb upstream of the first exon, respectively, were hypermethylated in tumors without MEG3 expression compared with the normal pituitary.

   Pubmed ID 15644399
   Year 2005
   Title Hypermethylation of the promoter region is associated with the loss of MEG3 gene expression in human pituitary tumors.
   External Links
   Links for  MEG3 GenBank       HGNC       lncrnadb       Noncode
   Links for  non-functioning pituitary adenoma Omim       Cosmic

CopyRight © College of Bioinformatics Science and Technology, Harbin Medical University, China.